Back to Results
First PageMeta Content
Tumor markers / Tumor suppressor genes / BRCA mutation / Breast cancer / Lactams / PARP inhibitor / BRCA2 / Ovarian cancer / BRCA1 / Medicine / Oncology / Mutation


ARIEL2: A phase 2 study to prospectively identify ovarian cancer patients likely to respond to rucaparib Elizabeth Swisher,1 James Brenton,2 Scott Kaufmann,3 Amit Oza,4 Robert L. Coleman,5 David O’Malley,6 Gottfried Ko
Add to Reading List

Document Date: 2014-11-25 16:41:42


Open Document

File Size: 1,36 MB

Share Result on Facebook
UPDATE